1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Andersen, N.H.
Cao, B.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
32
1407
1422
10.1021/bi00057a004
8431421
Hevein: NMR assignment and assessment of solution-state folding for the agglutinin-toxin motif.
1993
US
Biochem.Biophys.Res.Commun.
BBRCA9
0146
0006-291X
184
1008
Peptide(Slash)Protein Structure Analysis Using the Chemical Shift Index Method: Upfield Alpha-Ch Values Reveal Dynamic Helices and Alpha L Sites
1992
US
Biochemistry
BICHAW
0033
0006-2960
31
1280
Conformational Isomerism of Endothelin in Acidic Aqueous Media: A Quantitative Noesy Analysis
1992
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4731.166
HEVEIN
1
man
polymer
no
no
EQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKD
EQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKD
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Hevea
sample
3981
Hevea brasiliensis
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1994-01-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1993-01-14
REL
6
BRUNGER
refinement
X-PLOR
GLU
1
n
1
GLU
1
A
GLN
2
n
2
GLN
2
A
CYS
3
n
3
CYS
3
A
GLY
4
n
4
GLY
4
A
ARG
5
n
5
ARG
5
A
GLN
6
n
6
GLN
6
A
ALA
7
n
7
ALA
7
A
GLY
8
n
8
GLY
8
A
GLY
9
n
9
GLY
9
A
LYS
10
n
10
LYS
10
A
LEU
11
n
11
LEU
11
A
CYS
12
n
12
CYS
12
A
PRO
13
n
13
PRO
13
A
ASN
14
n
14
ASN
14
A
ASN
15
n
15
ASN
15
A
LEU
16
n
16
LEU
16
A
CYS
17
n
17
CYS
17
A
CYS
18
n
18
CYS
18
A
SER
19
n
19
SER
19
A
GLN
20
n
20
GLN
20
A
TRP
21
n
21
TRP
21
A
GLY
22
n
22
GLY
22
A
TRP
23
n
23
TRP
23
A
CYS
24
n
24
CYS
24
A
GLY
25
n
25
GLY
25
A
SER
26
n
26
SER
26
A
THR
27
n
27
THR
27
A
ASP
28
n
28
ASP
28
A
GLU
29
n
29
GLU
29
A
TYR
30
n
30
TYR
30
A
CYS
31
n
31
CYS
31
A
SER
32
n
32
SER
32
A
PRO
33
n
33
PRO
33
A
ASP
34
n
34
ASP
34
A
HIS
35
n
35
HIS
35
A
ASN
36
n
36
ASN
36
A
CYS
37
n
37
CYS
37
A
GLN
38
n
38
GLN
38
A
SER
39
n
39
SER
39
A
ASN
40
n
40
ASN
40
A
CYS
41
n
41
CYS
41
A
LYS
42
n
42
LYS
42
A
ASP
43
n
43
ASP
43
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
5
0.259
SIDE CHAIN
2
A
ARG
5
0.258
SIDE CHAIN
3
A
ARG
5
0.306
SIDE CHAIN
4
A
ARG
5
0.231
SIDE CHAIN
5
A
ARG
5
0.259
SIDE CHAIN
6
A
ARG
5
0.300
SIDE CHAIN
1
A
A
CG
CD2
HIS
HIS
35
35
0.058
0.009
1.354
1.412
N
2
A
A
CG
CD2
HIS
HIS
35
35
0.056
0.009
1.354
1.410
N
3
A
A
CG
CD2
HIS
HIS
35
35
0.058
0.009
1.354
1.412
N
4
A
A
CG
CD2
HIS
HIS
35
35
0.059
0.009
1.354
1.413
N
5
A
A
CG
CD2
HIS
HIS
35
35
0.058
0.009
1.354
1.412
N
6
A
A
CG
CD2
HIS
HIS
35
35
0.058
0.009
1.354
1.412
N
1
A
GLN
6
-73.61
30.73
1
A
ALA
7
-153.72
-5.43
1
A
ASN
14
51.63
17.29
1
A
LEU
16
-52.70
171.33
1
A
SER
26
-119.23
61.30
1
A
ASN
36
57.90
71.02
2
A
GLN
6
-86.03
37.11
2
A
ALA
7
-171.24
8.04
2
A
ASN
14
-79.58
20.55
2
A
SER
26
-116.49
63.35
3
A
GLN
6
-85.17
33.19
3
A
ALA
7
-162.12
-5.27
3
A
ASN
14
-75.49
24.93
3
A
TRP
21
-65.39
1.62
3
A
SER
26
-114.93
61.40
3
A
ASN
36
54.88
72.91
4
A
CYS
3
-166.69
-164.36
4
A
GLN
6
-95.23
39.89
4
A
ALA
7
-172.70
1.23
5
A
GLN
6
-73.61
30.73
5
A
ALA
7
-153.72
-5.43
5
A
ASN
14
51.63
17.29
5
A
LEU
16
-52.70
171.33
5
A
SER
26
-119.23
61.30
5
A
ASN
36
57.90
71.02
6
A
GLN
6
-85.44
33.63
6
A
ALA
7
-162.18
14.14
6
A
PRO
13
-63.13
20.77
6
A
ASN
14
73.32
-9.85
6
A
ASN
36
72.60
47.71
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
HEVEIN (NMR, 6 STRUCTURES)
HEVEIN: THE NMR ASSIGNMENT AND AN ASSESSMENT OF SOLUTION-STATE FOLDING FOR THE AGGLUTININ-TOXIN MOTIF
1
Y
N
A
ASP
28
A
ASP
28
HELX_P
A
CYS
31
A
CYS
31
1
A
4
A
PRO
33
A
PRO
33
HELX_P
A
HIS
35
A
HIS
35
5
B
3
disulf
2.039
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
18
A
SG
CYS
18
1_555
disulf
2.040
A
CYS
12
A
SG
CYS
12
1_555
A
CYS
24
A
SG
CYS
24
1_555
disulf
2.035
A
CYS
17
A
SG
CYS
17
1_555
A
CYS
31
A
SG
CYS
31
1_555
disulf
2.040
A
CYS
37
A
SG
CYS
37
1_555
A
CYS
41
A
SG
CYS
41
1_555
LECTIN
LECTIN
HEVE_HEVBR
UNP
1
1
P02877
MNIFIVVLLCLTGVAIAEQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKDSGEGVGGGSASNVLATYHLY
NSQDHGWDLNAASAYCSTWDANKPYSWRSKYGWTAFCGPVGAHGQSSCGKCLSVTNTGTGAKTTVRIVDQCSNGGLDLDV
NVFRQLDTDGKGYERGHITVNYQFVDCGDSFNPLFSVMKSSVIN
18
60
1HEV
1
43
P02877
A
1
1
43
3
anti-parallel
anti-parallel
A
TRP
23
A
TRP
23
A
SER
26
A
SER
26
A
LEU
16
A
LEU
16
A
SER
19
A
SER
19
A
GLN
38
A
GLN
38
A
ASN
40
A
ASN
40
1
P 1